Population pharmacokinetics of haloperidol in terminally ill adult patients

PURPOSE: Over 80% of the terminally ill patients experience delirium in their final days. In the treatment of delirium, haloperidol is the drug of choice. Very little is known about the pharmacokinetics of haloperidol in this patient population. We therefore designed a population pharmacokinetic stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Clin Pharmacol
Autors principals: Franken, L. G., Mathot, R. A. A., Masman, A. D., Baar, F. P. M., Tibboel, D., van Gelder, T., Koch, B. C. P., de Winter, B. C. M.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Pharmacokinetics and Disposition
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599451/
https://ncbi.nlm.nih.gov/pubmed/28681176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-017-2283-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars